Several talks expected to focus on the latest treatment updates, as well as some recently published data on COVID-19 symptoms and a commonly-used atopic dermatitis treatment.
Colleen Hall
Advertisement
Articles by Colleen Hall
Engage patients in treatment compliance and lifestyle changes to achieve optimal outcomes.
Advertisement
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Accepts sNDA for Roflumilast Cream 0.05% in Infants With Atopic Dermatitis Down to 3 Months
2
Teva Advances TEV-'408 Into Phase 2b for Vitiligo
3
Higher Cumulative Isotretinoin Dose May Reduce Acne Relapse
4
First-in-Class Oral Piclidenoson Reaches Pivotal Phase 3 Enrollment Milestone in Plaque Psoriasis
5